open access

Vol 3, No 2 (2018)
Original article
Published online: 2018-07-31
Get Citation

Early reoperations in chronic subdural hematoma

Borys M. Kwinta1, Roger M. Krzyżewski1, Kornelia Kliś1, Marek Moskała1
·
Medical Research Journal 2018;3(2):76-81.
Affiliations
  1. Department of Neurosurgery and Neurotraumatology, Jagiellonian University Medical College, Kraków, Poland, Botaniczna 3, 31-501 Kraków, Poland

open access

Vol 3, No 2 (2018)
ORIGINAL ARTICLES
Published online: 2018-07-31

Abstract

Background: The recurrence rate of chronic subdural hematoma (cSDH) is high and early reoperation is often required.

Aim: The aim of this study was to evaluate prognostic factors for early reoperation of chronic subdural hematomas (cSDH) treated by classical and minimally invasive approach. Materials and Methods: We retrospectively analyzed the medical history of 355 cSDH patients treated with formal craniotomy and minimally invasive burr hole craniostomy. We determined the potential predictors of early reoperations.

Results: A total of 33 (9.3%) patients required early reoperation. Those patients more often underwent craniotomies instead of burr hole craniostomies (36.4% vs. 62.7%, p < 0.01) and took steroids before hospitalization (3.0% vs. 0.3%, p = 0.04) than non-reoperated patients. Patients who had surgery on the right side were less likely to be reoperated (51.9% vs. 33.3%, p = 0.04). On multivariate analysis the frontal (OR = 5.284, 95% CI: 1.293–21.76, p = 0.019) and large craniotomy (OR = 2.297, 95% CI: 1.004–5.258, p = 0.048) remained independent risk factors for early reoperation of cSDH.

Conclusions: Neurosurgeons should consider the evacuation of a cSDH with help of minimally invasive burr hole craniostomy in most of the cases, as well as avoid large and frontal and craniotomies in order to prevent early reoperation of cSDH.

Abstract

Background: The recurrence rate of chronic subdural hematoma (cSDH) is high and early reoperation is often required.

Aim: The aim of this study was to evaluate prognostic factors for early reoperation of chronic subdural hematomas (cSDH) treated by classical and minimally invasive approach. Materials and Methods: We retrospectively analyzed the medical history of 355 cSDH patients treated with formal craniotomy and minimally invasive burr hole craniostomy. We determined the potential predictors of early reoperations.

Results: A total of 33 (9.3%) patients required early reoperation. Those patients more often underwent craniotomies instead of burr hole craniostomies (36.4% vs. 62.7%, p < 0.01) and took steroids before hospitalization (3.0% vs. 0.3%, p = 0.04) than non-reoperated patients. Patients who had surgery on the right side were less likely to be reoperated (51.9% vs. 33.3%, p = 0.04). On multivariate analysis the frontal (OR = 5.284, 95% CI: 1.293–21.76, p = 0.019) and large craniotomy (OR = 2.297, 95% CI: 1.004–5.258, p = 0.048) remained independent risk factors for early reoperation of cSDH.

Conclusions: Neurosurgeons should consider the evacuation of a cSDH with help of minimally invasive burr hole craniostomy in most of the cases, as well as avoid large and frontal and craniotomies in order to prevent early reoperation of cSDH.

Get Citation

Keywords

reoperation, minimally invasive approach, chronic subdural hematoma, burr hole, craniotomy

About this article
Title

Early reoperations in chronic subdural hematoma

Journal

Medical Research Journal

Issue

Vol 3, No 2 (2018)

Article type

Original article

Pages

76-81

Published online

2018-07-31

Page views

697

Article views/downloads

845

DOI

10.5603/MRJ.2018.0013

Bibliographic record

Medical Research Journal 2018;3(2):76-81.

Keywords

reoperation
minimally invasive approach
chronic subdural hematoma
burr hole
craniotomy

Authors

Borys M. Kwinta
Roger M. Krzyżewski
Kornelia Kliś
Marek Moskała

References (34)
  1. Wan Yi, Fei X, Jiang D, et al. Clinical Observation of Treatment of Chronic Subdural Hematoma With Novel Double Needle Minimally Invasive Aspiration Technology. J Craniofac Surg. 2017; 28(3): 646–649.
  2. Yang W, Huang J. Chronic Subdural Hematoma: Epidemiology and Natural History. Neurosurg Clin N Am. 2017; 28(2): 205–210.
  3. Toi H, Kinoshita K, Hirai S, et al. Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. J Neurosurg. 2018; 128(1): 222–228.
  4. Almenawer SA, Farrokhyar F, Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg. 2014; 259(3): 449–457.
  5. Brennan PM, Kolias AG, Joannides AJ, et al. British Neurosurgical Trainee Research Collaborative, British Neurosurgical Trainee Research Collaborative. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg. 2017; 127(4): 732–739.
  6. Soleman J, Nocera F, Mariani L. The conservative and pharmacological management of chronic subdural haematoma. Swiss Med Wkly. 2017; 147: w14398.
  7. Jablawi F, Kweider H, Nikoubashman O, et al. Twist Drill Procedure for Chronic Subdural Hematoma Evacuation: An Analysis of Predictors for Treatment Success. World Neurosurg. 2017; 100: 480–486.
  8. Sahyouni R, Mahboubi H, Tran P, et al. Membranectomy in Chronic Subdural Hematoma: Meta-Analysis. World Neurosurg. 2017; 104: 418–429.
  9. Ro HW, Park SK, Jang DK, et al. Preoperative predictive factors for surgical and functional outcomes in chronic subdural hematoma. Acta Neurochir (Wien). 2016; 158(1): 135–139.
  10. Weimer JM, Gordon E, Frontera JA. Predictors of Functional Outcome After Subdural Hematoma: A Prospective Study. Neurocrit Care. 2017; 26(1): 70–79.
  11. Toi H, Kinoshita K, Hirai S, et al. Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. J Neurosurg. 2018; 128(1): 222–228.
  12. Lukasiewicz AM, Grant RA, Basques BA, et al. Patient factors associated with 30-day morbidity, mortality, and length of stay after surgery for subdural hematoma: a study of the American College of Surgeons National Surgical Quality Improvement Program. J Neurosurg. 2016; 124(3): 760–766.
  13. Manickam A, Marshman LAG, Johnston R. Long-term survival after chronic subdural haematoma. J Clin Neurosci. 2016; 34: 100–104.
  14. Han MH, Ryu JeIl, Kim CH, et al. Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma. J Neurosurg. 2017; 127(5): 1117–1125.
  15. Weigel R, Schmiedek P, Krauss JK. Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry. 2003; 74(7): 937–943.
  16. Oh HJ, Lee KS, Shim JJ, et al. Postoperative course and recurrence of chronic subdural hematoma. J Korean Neurosurg Soc. 2010; 48(6): 518–523.
  17. Torihashi K, Sadamasa N, Yoshida K, et al. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery. 2008; 63(6): 1125–9; discussion 1129.
  18. Yamamoto H, Hirashima Y, Hamada H, et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg. 2003; 98(6): 1217–1221.
  19. Lee J, Park J, Kim J. Retrospective Analysis of Risk Factors for Recurrent Chronic Subdural Hematoma. The Nerve. 2016; 2(2): 54–58.
  20. Song DH, Kim YS, Chun HJ, et al. The Predicting Factors for Recurrence of Chronic Subdural Hematoma Treated with Burr Hole and Drainage. Korean J Neurotrauma. 2014; 10(2): 41–48.
  21. Santarius T, Kirkpatrick PJ, Ganesan D, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet. 2009; 374(9695): 1067–1073.
  22. Jung YG, Jung NY, Kim El. Independent predictors for recurrence of chronic subdural hematoma. J Korean Neurosurg Soc. 2015; 57(4): 266–270.
  23. Buchanan IA, Mack WJ. Minimally Invasive Surgical Approaches for Chronic Subdural Hematomas. Neurosurg Clin N Am. 2017; 28(2): 219–227.
  24. Schulz W, Saballus R, Flügel R, et al. [Chronic subdural hematoma. A comparison of bore hole trepanation and craniotomy]. Zentralbl Neurochir. 1988; 49(4): 280–289.
  25. Hamilton MG, Frizzell JB, Tranmer BI. Chronic subdural hematoma: the role for craniotomy reevaluated. Neurosurgery. 1993; 33(1): 67–72.
  26. Taussky P, Fandino J, Landolt H. Number of burr holes as independent predictor of postoperative recurrence in chronic subdural haematoma. Br J Neurosurg. 2008; 22(2): 279–282.
  27. Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev. 2012; 35(2): 155–69; discussion 169.
  28. Yadav YR, Parihar V, Chourasia ID, et al. The role of subgaleal suction drain placement in chronic subdural hematoma evacuation. Asian J Neurosurg. 2016; 11(3): 214–218.
  29. Mori K, Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo). 2001; 41(8): 371–381.
  30. Chen CW, Kuo JR, Lin HJ, et al. Early post-operative seizures after burr-hole drainage for chronic subdural hematoma: correlation with brain CT findings. J Clin Neurosci. 2004; 11(7): 706–709.
  31. Kong WK, Kim BC, Cho KT, et al. Factors Affecting Postoperative Recurrence of Chronic Subdural Hematoma. Korean Journal of Neurotrauma. 2012; 8(2): 122.
  32. Dran G, Berthier F, Fontaine D, et al. [Effectiveness of adjuvant corticosteroid therapy for chronic subdural hematoma: a retrospective study of 198 cases]. Neurochirurgie. 2007; 53(6): 477–482.
  33. Berghauser Pont LME, Dammers R, Schouten JW, et al. Clinical factors associated with outcome in chronic subdural hematoma: a retrospective cohort study of patients on preoperative corticosteroid therapy. Neurosurgery. 2012; 70(4): 873–80; discussion 880.
  34. Berghauser Pont LME, Dirven CMF, Dippel DWJ, et al. The role of corticosteroids in the management of chronic subdural hematoma: a systematic review. Eur J Neurol. 2012; 19(11): 1397–1403.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl